Extrahepatic Portosystemic Shunt Ligation

Medical management — low-protein diet, lactulose, and antibiotics to reduce ammonia production — can temporarily improve a pet's neurological signs but does not correct the underlying shunt. Over time, the underperfused liver continues to atrophy, and medical control eventually becomes inadequate. Surgical ligation, when performed before irreversible liver damage has occurred, allows the liver to grow and assume normal metabolic function. Outcomes are meaningfully better in pets operated on earlier in the course of disease. The ameroid constrictor is preferred over acute ligation because gradual closure minimizes the risk of portal hypertension — a dangerous spike in portal blood pressure that can occur if the shunt is closed too quickly.

The procedure is performed under general anesthesia with careful anesthetic planning, because animals with PSS are unusually sensitive to sedative drugs. Steps include:

• The abdomen is opened and the portal vasculature is carefully traced to identify the shunt vessel
• The shunt is isolated from surrounding structures; intraoperative portal pressure measurement may be used to gauge how much closure can be tolerated acutely
• An ameroid constrictor — a ring of hygroscopic (water-absorbing) casein material inside a stainless-steel shell — is placed around the shunt vessel
• As the casein absorbs fluid over the following two to four weeks it expands inward, progressively narrowing and eventually closing the vessel
• The abdomen is closed routinely

Because the closure is gradual, the portal circulation has time to redistribute blood to the liver without a sudden pressure spike. Most extrahepatic shunts in dogs and cats are single vessels amenable to this approach.

Thorough pre-operative workup is essential. The team performs abdominal ultrasound (with Doppler to visualize blood flow through the shunt), fasting and post-prandial bile acid tests to quantify liver dysfunction, full bloodwork including ammonia level and clotting times, and urinalysis with sediment (ammonium biurate crystals are a hallmark finding). Any neurological signs are stabilized with lactulose and a low-protein diet in the days before surgery. Specialized anesthetic protocols minimize the use of drugs cleared by a poorly functioning liver, and the team maintains a warmed surgical environment to prevent hypothermia. Food is withheld for twelve hours before anesthesia; water instructions are provided individually.

Hospitalization is typically two to three days, during which the team monitors for post-operative seizures — an uncommon but recognized complication after shunt attenuation. At home, recovery follows this path:

• Weeks 1–4: medical management (lactulose, antibiotics, low-protein diet) is continued while the ameroid constrictor closes the shunt; some neurological signs may temporarily worsen as blood flow shifts
• Week 4–8: bile acid retest confirms that shunt closure is progressing and the liver is improving
• Month 3–6: most pets have meaningful clinical improvement; a repeat bile acid test and ultrasound assess the liver's recovery

Many animals can reduce or discontinue their medications as liver function improves, though some require lifelong management if the liver did not fully recover. Activity is restricted during the immediate post-operative period.

Portosystemic shunt ligation carries procedure-specific risks. The most serious post-operative complication is portal hypertension with acute abdomen or post-ligation seizures, which can occur even with gradual closure and requires immediate intensive management. Other risks include incomplete shunt closure (requiring additional intervention), shunt recurrence, acquired hepatic microvascular dysplasia in the remaining liver, and — in a small number of cases — development of multiple acquired shunts if the primary shunt is closed too quickly. Despite these considerations, surgical attenuation with an ameroid constrictor has favorable reported outcomes, with the majority of operated animals achieving a significant improvement in quality of life and liver function. Intrahepatic shunts (located within the liver itself) are less common and technically more demanding; if one is identified on pre-operative imaging, surgical planning is adjusted accordingly.